Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

DDermata Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
D

Dermata Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Aug 16, 2026Van Hoose Kyri K.SVP, CFO102,040Series F Warrant (Right to Buy)—Grant / award
Aug 16, 2026Van Hoose Kyri K.SVP, CFO102,040Series E Warrant (Right to Buy)—Grant / award
Aug 16, 2026Van Hoose Kyri K.SVP, CFO102,040Common Stock—Grant / award
Aug 16, 2026PROEHL GERALD TPRESIDENT, CHAIRMAN, CEO1,360,544Pre-Funded Warrant (Right to Buy)—Grant / award
Aug 16, 2026PROEHL GERALD TPRESIDENT, CHAIRMAN, CEO1,530,612Series F Warrant (Right to Buy)—Grant / award
Aug 16, 2026PROEHL GERALD TPRESIDENT, CHAIRMAN, CEO1,530,612Series E Warrant (Right to Buy)—Grant / award
Aug 16, 2026PROEHL GERALD TPRESIDENT, CHAIRMAN, CEO170,068Common Stock—Grant / award
Jun 16, 2026Scott Kathleen D.Director11Common Stock—Sell
Feb 17, 2026Bedoya-Toro Munera Maria ESVP, Regulatory Affairs1,000Common Stock—Buy
Jan 2, 2026Bradrick BrittanyDirector2,500Stock Option (Right to Buy)—Grant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions